Standard Chemical & Pharmaceutical Statistics

Total Valuation

Standard Chemical & Pharmaceutical has a market cap or net worth of TWD 11.53 billion. The enterprise value is 13.33 billion.

Market Cap	11.53B
Enterprise Value	13.33B

Important Dates

The next estimated earnings date is Tuesday, November 5, 2024.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	Aug 1, 2024

Share Statistics

Standard Chemical & Pharmaceutical has 178.70 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Shares Outstanding	178.70M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	47.57%
Owned by Institutions (%)	6.02%
Float	82.25M

Valuation Ratios

The trailing PE ratio is 13.50.

PE Ratio	13.50
Forward PE	n/a
PS Ratio	1.74
PB Ratio	1.98
P/FCF Ratio	16.86
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.66, with an EV/FCF ratio of 19.49.

EV / Earnings	15.60
EV / Sales	2.02
EV / EBITDA	7.66
EV / EBIT	9.80
EV / FCF	19.49

Financial Position

The company has a current ratio of 2.16, with a Debt / Equity ratio of 9.36.

Current Ratio	2.16
Quick Ratio	1.43
Debt / Equity	9.36
Debt / EBITDA	0.47
Debt / FCF	1.19
Interest Coverage	62.41

Financial Efficiency

Return on equity (ROE) is 14.88% and return on invested capital (ROIC) is 9.10%.

Return on Equity (ROE)	14.88%
Return on Assets (ROA)	7.30%
Return on Capital (ROIC)	9.10%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.58
Inventory Turnover	2.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.39% in the last 52 weeks. The beta is 0.13, so Standard Chemical & Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	-1.39%
50-Day Moving Average	68.46
200-Day Moving Average	67.45
Relative Strength Index (RSI)	38.42
Average Volume (20 Days)	293,733

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Standard Chemical & Pharmaceutical had revenue of TWD 6.61 billion and earned 854.07 million in profits. Earnings per share was 4.78.

Revenue	6.61B
Gross Profit	2.90B
Operating Income	1.34B
Pretax Income	1.52B
Net Income	854.07M
EBITDA	1.69B
EBIT	1.34B
Earnings Per Share (EPS)	4.78

Full Income Statement

Balance Sheet

The company has 1.87 billion in cash and 811.68 million in debt, giving a net cash position of 1.05 billion or 5.90 per share.

Cash & Cash Equivalents	1.87B
Total Debt	811.68M
Net Cash	1.05B
Net Cash Per Share	5.90
Equity (Book Value)	8.67B
Book Value Per Share	32.57
Working Capital	2.87B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.26 billion and capital expenditures -577.10 million, giving a free cash flow of 683.67 million.

Operating Cash Flow	1.26B
Capital Expenditures	-577.10M
Free Cash Flow	683.67M
FCF Per Share	3.83

Full Cash Flow Statement

Margins

Gross margin is 43.86%, with operating and profit margins of 20.29% and 12.92%.

Gross Margin	43.86%
Operating Margin	20.29%
Pretax Margin	22.93%
Profit Margin	12.92%
EBITDA Margin	25.63%
EBIT Margin	20.29%
FCF Margin	10.34%

Dividends & Yields

This stock pays an annual dividend of 2.70, which amounts to a dividend yield of 4.24%.

Dividend Per Share	2.70
Dividend Yield	4.24%
Dividend Growth (YoY)	8.00%
Years of Dividend Growth	n/a
Payout Ratio	52.31%
Buyback Yield	0.01%
Shareholder Yield	4.25%
Earnings Yield	7.41%
FCF Yield	5.93%

Dividend Details

Stock Splits

The last stock split was on August 19, 2011. It was a forward split with a ratio of 1.07.

Last Split Date	Aug 19, 2011
Split Type	Forward
Split Ratio	1.07